FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis

Abstract Bone formation, metabolism, and the stability of the bone marrow microenvironment are all impacted by the imbalance in the differentiation potential of bone marrow mesenchymal stem cells (BMSCs). Despite this, it is unknown how BMSCs affect congenital scoliosis (CS). As a result, our resear...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Dai, Gang Xiang, Jiong Li, Gengming Zhang, Guanteng Yang, Lige Xiao, Yunjia Wang, Hongqi Zhang
Format: Article
Language:English
Published: Nature Portfolio 2025-07-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-13044-w
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849332981476360192
author Jie Dai
Gang Xiang
Jiong Li
Gengming Zhang
Guanteng Yang
Lige Xiao
Yunjia Wang
Hongqi Zhang
author_facet Jie Dai
Gang Xiang
Jiong Li
Gengming Zhang
Guanteng Yang
Lige Xiao
Yunjia Wang
Hongqi Zhang
author_sort Jie Dai
collection DOAJ
description Abstract Bone formation, metabolism, and the stability of the bone marrow microenvironment are all impacted by the imbalance in the differentiation potential of bone marrow mesenchymal stem cells (BMSCs). Despite this, it is unknown how BMSCs affect congenital scoliosis (CS). As a result, our research now focuses on explaining its associated impact and mechanism. In eukaryotic cells, N6-methyladenosine (m6A) is the most prevalent post-transcriptional alteration. The role of fat mass and obesity-related genes (FTO), an m6A demethylase, in regulating the differentiation of BMSCs is still unknown. We assessed alterations in the mRNA and protein levels of genes linked to the differentiation of BMSCs using samples taken from CS. According to our findings, According to our findings, FTO inhibits osteogenic differentiation and promotes the adipogenic differentiation of BMSCs. MMP1 knockdown has an inhibitory effect on BMSC osteogenic differentiation, whereas MMP1 overexpression promotes it. A specific ERG inhibitor called PD98059 prevents MMP1-mediated promotion. Additionally, our research revealed that FTO affects how BMSCs can differentiate in CS patients by regulating MMP1 levels. FTO-mediated MMP1 m6A modification underlies MMP1’s promotion of osteogenic differentiation via the ERK pathway, implying that it could be a viable treatment target for CS.
format Article
id doaj-art-90ae6c3e89394b2cbba0bc0db1022b83
institution Kabale University
issn 2045-2322
language English
publishDate 2025-07-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-90ae6c3e89394b2cbba0bc0db1022b832025-08-20T03:46:01ZengNature PortfolioScientific Reports2045-23222025-07-0115111310.1038/s41598-025-13044-wFTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosisJie Dai0Gang Xiang1Jiong Li2Gengming Zhang3Guanteng Yang4Lige Xiao5Yunjia Wang6Hongqi Zhang7Department of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityDepartment of Spine Surgery and Orthopaedics, Xiangya Hospital, Central South UniversityAbstract Bone formation, metabolism, and the stability of the bone marrow microenvironment are all impacted by the imbalance in the differentiation potential of bone marrow mesenchymal stem cells (BMSCs). Despite this, it is unknown how BMSCs affect congenital scoliosis (CS). As a result, our research now focuses on explaining its associated impact and mechanism. In eukaryotic cells, N6-methyladenosine (m6A) is the most prevalent post-transcriptional alteration. The role of fat mass and obesity-related genes (FTO), an m6A demethylase, in regulating the differentiation of BMSCs is still unknown. We assessed alterations in the mRNA and protein levels of genes linked to the differentiation of BMSCs using samples taken from CS. According to our findings, According to our findings, FTO inhibits osteogenic differentiation and promotes the adipogenic differentiation of BMSCs. MMP1 knockdown has an inhibitory effect on BMSC osteogenic differentiation, whereas MMP1 overexpression promotes it. A specific ERG inhibitor called PD98059 prevents MMP1-mediated promotion. Additionally, our research revealed that FTO affects how BMSCs can differentiate in CS patients by regulating MMP1 levels. FTO-mediated MMP1 m6A modification underlies MMP1’s promotion of osteogenic differentiation via the ERK pathway, implying that it could be a viable treatment target for CS.https://doi.org/10.1038/s41598-025-13044-wCongenital scoliosisBone marrow mesenchymal stem cellsm6A methylationOsteogenic differentiationSignal transduction pathway
spellingShingle Jie Dai
Gang Xiang
Jiong Li
Gengming Zhang
Guanteng Yang
Lige Xiao
Yunjia Wang
Hongqi Zhang
FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
Scientific Reports
Congenital scoliosis
Bone marrow mesenchymal stem cells
m6A methylation
Osteogenic differentiation
Signal transduction pathway
title FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
title_full FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
title_fullStr FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
title_full_unstemmed FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
title_short FTO-mediated MMP1 m6A modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the ERK pathway in congenital scoliosis
title_sort fto mediated mmp1 m6a modification promotes osteogenic differentiation of bone marrow mesenchymal stem cells via the erk pathway in congenital scoliosis
topic Congenital scoliosis
Bone marrow mesenchymal stem cells
m6A methylation
Osteogenic differentiation
Signal transduction pathway
url https://doi.org/10.1038/s41598-025-13044-w
work_keys_str_mv AT jiedai ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT gangxiang ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT jiongli ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT gengmingzhang ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT guantengyang ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT ligexiao ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT yunjiawang ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis
AT hongqizhang ftomediatedmmp1m6amodificationpromotesosteogenicdifferentiationofbonemarrowmesenchymalstemcellsviatheerkpathwayincongenitalscoliosis